Israeli vaccine Phase 2 trials commence

Israel’s Institute for Biological Research IIBR (see here previously) has stated that it has delivered 1,000 doses of its BriLife coronavirus vaccine to Georgia for starting Phase 2 trials. IIBR’s partner, NRx, will lead the trials, expand patient numbers and prepare for Phase 3.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *